首页> 外文期刊>investigative radiology >Prekallikrein Activation, C1 Esterase Inhibitor, and Factor XII as Predictors of Adverse Reaction to Contrast MediaA Prospective Study
【24h】

Prekallikrein Activation, C1 Esterase Inhibitor, and Factor XII as Predictors of Adverse Reaction to Contrast MediaA Prospective Study

机译:前激肽释放酶活化、C1 酯酶抑制剂和因子 XII 作为造影剂不良反应的预测因子前瞻性研究

获取原文
获取外文期刊封面目录资料

摘要

The susceptibility of 152 patients to idiosyncratic reactions resulting from the administration of radiographic contrast media was studied. The rate of activation of plasma prekallikrein was measured in samples taken from these patients before they received contrast agents. Kallikrein inhibitor and factor XII levels were also determined. The tests were of no value in selecting the ten patients who subsequently experienced mild reactions. However, the possibility remains that one or more of the tests may have predictive value for patients who experience moderate or severe reactions.
机译:研究了 152 名患者对放射造影剂施用引起的特异质反应的易感性。血浆前激肽释放酶的活化率是在这些患者接受造影剂之前采集的样本中测量的。还测定了激肽释放酶抑制剂和因子 XII 水平。这些测试在选择随后出现轻微反应的十名患者时没有价值。然而,一项或多项测试可能对出现中度或重度反应的患者具有预测价值。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号